Skip to main content
. 2016 Nov 29;8(2):2372–2380. doi: 10.18632/oncotarget.13676

Table 1. Summary of worst neoplastic diseases in the lower reproductive tract of K14E6/K14E7 mice*.

Group Group size,n No disease Dysplasia only Cancer & dysplasia Cancer incidence,% Multiplicity (Mean ± S.E.M)
CIN1(VaIN1) CIN2(VaIN2) CIN3(VaIN3)
Primary 7 0 (0) 0 (1) 0 (4) 0 (1) 7 (1) 100 (14.3) 1.7±0.2(0.1±0.1)
Therapy 6 6 (6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
De Novo 16 4 (6) 1 (2) 5 (4) 2 (1) 4 (3) 25 (18.8) 0.8±0.4(0.3±0.1)
Recurrence (+E2) 6 0 (0) 0 (1) 0 (0) 0 (1) 6 (4) 100 (66.7) 3.0±0.7(2.0±0.9)
Recurrence (−E2) 6 0 (1) 0 (1) 0 (0) 0 (0) 6 (4) 100 (66.7) 3.0±0.4(1.3±0.5)
Prevention 7 0 (1) 0 (2) 0 (2) 0 (0) 7 (2) 100 (28.6) 2.1±0.3(0.3±0.5)
Recurrence therapy 7# 0 (1) 0 (0) 0 (0) 0 (1) 7 (5) 100 (71.4) 3.1±0.7(0.9±0.3)
Control 5 0 (1) 0 (0) 0 (1) 0 (0) 5 (3) 100 (60.0) 3.2±0.5(1.2±0.6)
*

Mice were scored histopathologically for the worst disease present in the cervix or, in parentheses, the vagina of each mouse. CIN, cervical intraepithelial neoplasia; VaIN, vaginal intraepithelial neoplasia. P < 0.01 compared to the other groups. #One mouse did not have mucinified cervical epithelium, suggesting that MPA treatment did not work in that mouse. This mouse was excluded from statistical analyses.